Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

IO Learning

Advertisement

Recent Content

News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
Charles Martin, MD
Commentary
Championing Change in Medical Imaging and Care Delivery with Augmented Imaging
06/26/2024
In this commentary, Charles Martin, MD, discusses the advancing of imaging technologies and how interventional radiologists may be able to use AR to assist in their treatment.
In this commentary, Charles Martin, MD, discusses the advancing of imaging technologies and how interventional radiologists may be able to use AR to assist in their treatment.
In this commentary, Charles...
06/26/2024
IO Learning
Katerina Lee, MD
Podcasts
Augmented Reality for Multi-Needle Composite Liver Tumor Ablation
06/20/2024
Katerina Lee, MD
Andrew Kolarich, MD
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO...
06/20/2024
IO Learning
Osman Ahmed, MD, University of Chicago Medicine
Videos
Histotripsy: Current and Future Applications
05/09/2024

Featuring Osman Ahmed, MD

Featuring Osman Ahmed, MD
Osman Ahmed, MD, gives an overview of histotripsy and explains the recent #HOPE4LIVER trial, looking the safety and efficacy of this technique for liver tumors.
Osman Ahmed, MD, gives an overview of histotripsy and explains the recent #HOPE4LIVER trial, looking the safety and efficacy of this technique for liver tumors.
Osman Ahmed, MD, gives an...
05/09/2024
IO Learning
Christos Georgiades, MD, PhD, Johns Hopkins Hospital
Videos
Physics of Histotripsy
05/09/2024

Featuring Christos Georgiades, MD, PhD

Featuring Christos Georgiades, MD, Ph...
Christos Georgiades, MD, PhD, explains the physics of histotripsy and how this technique differs from existing interventional oncology treatments.
Christos Georgiades, MD, PhD, explains the physics of histotripsy and how this technique differs from existing interventional oncology treatments.
Christos Georgiades, MD, PhD,...
05/09/2024
IO Learning
Dania Daye, MD, PhD, Massachusetts General Hospital
Podcasts
How Artificial Intelligence May Change Interventional Oncology
04/23/2024

Featuring Dania Daye, MD, PhD

Featuring Dania Daye, MD, PhD
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this...
04/23/2024
IO Learning
Robert Abraham, MD, FSIR, FRCPC, Dalhousie University
Conference Coverage
Potential of Imageable Glass Y90 Microspheres for Radioembolization Among Patients With Hepatocellular Carcinoma
04/18/2024

Featuring Robert Abraham, MD, FSIR, FRCPC

Featuring Robert Abraham, MD, FSIR, F...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting,...
04/18/2024
IO Learning
Kevin P. Henseler, MD, FACR, Midwest Radiology
Conference Coverage
Unique Shear-Thinning Hydrogel Embolic Material Demonstrates Feasibility
04/16/2024

Featuring Kevin P. Henseler, MD, FACR

Featuring Kevin P. Henseler, MD, FACR...
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR,...
04/16/2024
IO Learning
Daniel B. Brown, MD, FSIR
Videos
Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
Qian (Clark) Yu, MD, University of Chicago
Conference Coverage
Combining Transarterial Radioembolization and Systemic Therapy for Unresectable Cholangiocarcinoma
04/12/2024

Featuring Qian (Clark) Yu, MD

Featuring Qian (Clark) Yu, MD
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting,...
04/12/2024
IO Learning

Highlights From CIO

Conference Coverage
Treating Liver and Colorectal Metastases: A Comprehensive Overview of Recent Data
02/02/2024

Samantha Hager

Samantha Hager
Nadine Abi-Jaoudeh, MD, provides a comprehensive overview of recent study data and innovative treatment approaches for liver and colorectal metastases at the 2023 Symposium of Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, provides a comprehensive overview of recent study data and innovative treatment approaches for liver and colorectal metastases at the 2023 Symposium of Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, provides...
02/02/2024
IO Learning
Conference Coverage
The Latest Updates and Ongoing Controversies in HCC Treatment: A Roundtable Discussion
02/02/2024

Samantha Hager

Samantha Hager
At the 2023 Symposium on Clinical Interventional Oncology, Edward Kim, MD, led a panel discussion exploring current hot topics and ongoing controversies in HCC treatment.
At the 2023 Symposium on Clinical Interventional Oncology, Edward Kim, MD, led a panel discussion exploring current hot topics and ongoing controversies in HCC treatment.
At the 2023 Symposium on...
02/02/2024
IO Learning
Conference Coverage
Advances in Systemic Therapy for HCC
02/02/2024

Samantha Hager

Samantha Hager
Fernando De Zarraga, MD, presented an in-depth discussion highlighting significant advancements in systemic therapy for HCC at the 2023 Symposium on Clinical Interventional Oncology.
Fernando De Zarraga, MD, presented an in-depth discussion highlighting significant advancements in systemic therapy for HCC at the 2023 Symposium on Clinical Interventional Oncology.
Fernando De Zarraga, MD,...
02/02/2024
IO Learning
Dr. Michael Chuong
CIO2023 Highlights
Which Liver Patients are Best Treated with External Beam Radiation?
01/05/2024
Michael Chuong, MD, radiation oncologist at Miami Cancer Institute, delivered a presentation focusing on the role of external beam radiation therapy (EBRT) in the treatment of liver cancer during a session at the 2023 Symposium on Clinical...
Michael Chuong, MD, radiation oncologist at Miami Cancer Institute, delivered a presentation focusing on the role of external beam radiation therapy (EBRT) in the treatment of liver cancer during a session at the 2023 Symposium on Clinical...
Michael Chuong, MD, radiation...
01/05/2024
IO Learning
Dr. Robert Suh
CIO2023 Highlights
Lung Biopsy or Ablation Related Life-Threatening Bleeding: How I Manage It
01/05/2024
Robert Suh, MD of the David Geffen School of Medicine at UCLA, presents on the critical topic of lung biopsy or ablation-related hemorrhage, providing insights into the differentiation and management of three distinct types of bleeds...
Robert Suh, MD of the David Geffen School of Medicine at UCLA, presents on the critical topic of lung biopsy or ablation-related hemorrhage, providing insights into the differentiation and management of three distinct types of bleeds...
Robert Suh, MD of the David...
01/05/2024
IO Learning
Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst
CIO2023 Highlights
Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst
01/05/2024
Marisabel Bolsegui discusses her CIO2023 abstract, "CIO 2023-14 Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst."
Marisabel Bolsegui discusses her CIO2023 abstract, "CIO 2023-14 Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst."
Marisabel Bolsegui discusses her...
01/05/2024
IO Learning
Ebstesam Nafie
CIO2023 Highlights
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
12/14/2023
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her...
12/14/2023
IO Learning
The Evolving Role of Hepatic Ablation with Dr. Raul Uppot
CIO2023 Highlights
The Evolving Role of Hepatic Ablation with Dr. Raul Uppot
12/14/2023
Dr. Raul Uppot, MD, from Massachusetts General Hospital, delivered a comprehensive presentation on the dynamic landscape of hepatic ablation during CIO 2023. 
Dr. Raul Uppot, MD, from Massachusetts General Hospital, delivered a comprehensive presentation on the dynamic landscape of hepatic ablation during CIO 2023. 
Dr. Raul Uppot, MD, from...
12/14/2023
IO Learning
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
12/08/2023
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
IO Learning
Case Based Lung Ablation: Top 5 Clinical and Technical Pearls
CIO2023 Highlights
Case Based Lung Ablation: Top 5 Clinical and Technical Pearls
12/07/2023
Steven Yevich, MD, MPH, of MD Anderson Cancer Center, presented, "Case-Based Lung Ablation: Top Five Clinical and Technical Pearls", a session aimed to provide essential insights into lung ablation, a rapidly growing field within...
Steven Yevich, MD, MPH, of MD Anderson Cancer Center, presented, "Case-Based Lung Ablation: Top Five Clinical and Technical Pearls", a session aimed to provide essential insights into lung ablation, a rapidly growing field within...
Steven Yevich, MD, MPH, of MD...
12/07/2023
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
Allison Casey
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023

Julia Evangelou Strait

Julia Evangelou Strait
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement